Work

Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxis

Year: 2025

Type: article

Source: The Lancet HIV

DOI: 10.1016/s2352-3018(25)00128-6

Authors: Gert van Zyl, Mateo Prochazka, Heather-Marie Ann Schmidt, Catherine Orrell, Jonathan M Schapiro, Suzanne M McCluskey, Marco Vitoria, Rami Kantor, Urvi M Parikh, Michelle Rodolph, Michael R Jordan, Robert W Shafer

Institutions: National Health Laboratory Service, Stellenbosch University, World Health Organization, University of Cape Town, Sheba Medical Center, Harvard University, Brown University, University of Pittsburgh, Tufts Medical Center, Universidade Nova de Lisboa, Stanford Medicine, Stanford University

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: World Health Organization, National Institute of Allergy and Infectious Diseases

Award: G5539432488

OpenAlex ID: W4411405406

FWCI: 9.86

Cites: 29

Cited by: 14

Related to: 10